380 related articles for article (PubMed ID: 35021983)
21. [Transport of PLGA nanoparticles across Caco-2/HT29-MTX co-cultured cells].
Wen Z; Li G; Lin DH; Wang JT; Qin LF; Guo GP
Yao Xue Xue Bao; 2013 Dec; 48(12):1829-35. PubMed ID: 24689242
[TBL] [Abstract][Full Text] [Related]
22. Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease.
Meng Q; Wang A; Hua H; Jiang Y; Wang Y; Mu H; Wu Z; Sun K
Int J Nanomedicine; 2018; 13():705-718. PubMed ID: 29440896
[TBL] [Abstract][Full Text] [Related]
23. Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4.
Wang M; Zhang Y; Feng J; Gu T; Dong Q; Yang X; Sun Y; Wu Y; Chen Y; Kong W
Int J Nanomedicine; 2013; 8():1141-54. PubMed ID: 23658482
[TBL] [Abstract][Full Text] [Related]
24. Electrohydrodynamic fabrication of core-shell PLGA nanoparticles with controlled release of cisplatin for enhanced cancer treatment.
Reardon PJ; Parhizkar M; Harker AH; Browning RJ; Vassileva V; Stride E; Pedley RB; Edirisinghe M; Knowles JC
Int J Nanomedicine; 2017; 12():3913-3926. PubMed ID: 28579777
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, characterization, and evaluation of in vitro cytotoxicity and in vivo antitumor activity of asiatic acid-loaded poly lactic-co-glycolic acid nanoparticles: A strategy of treating breast cancer.
Dutta S; Chakraborty P; Basak S; Ghosh S; Ghosh N; Chatterjee S; Dewanjee S; Sil PC
Life Sci; 2022 Oct; 307():120876. PubMed ID: 35961595
[TBL] [Abstract][Full Text] [Related]
26. Micelle-templated, poly(lactic-
Nabar GM; Mahajan KD; Calhoun MA; Duong AD; Souva MS; Xu J; Czeisler C; Puduvalli VK; Otero JJ; Wyslouzil BE; Winter JO
Int J Nanomedicine; 2018; 13():351-366. PubMed ID: 29391794
[TBL] [Abstract][Full Text] [Related]
27. Development of α-tocopherol surface-modified targeted delivery of 5-fluorouracil-loaded poly-D, L-lactic-co-glycolic acid nanoparticles against oral squamous cell carcinoma.
Srivastava S; Gupta S; Mohammad S; Ahmad I
J Cancer Res Ther; 2019; 15(3):480-490. PubMed ID: 31169208
[TBL] [Abstract][Full Text] [Related]
28. Lenvatinib-Loaded Poly(lactic-co-glycolic acid) Nanoparticles with Epidermal Growth Factor Receptor Antibody Conjugation as a Preclinical Approach to Therapeutically Improve Thyroid Cancer with Aggressive Behavior.
Revilla G; Al Qtaish N; Caruana P; Sainz-Ramos M; Lopez-Mendez T; Rodriguez F; Paez-Espinosa V; Li C; Vallverdú NF; Edwards M; Moral A; Pérez JI; Escolà-Gil JC; Pedraz JL; Gallego I; Corcoy R; Céspedes MV; Puras G; Mato E
Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002329
[TBL] [Abstract][Full Text] [Related]
29. [Preparation and in vitro evaluation of pDNA-CaPi-PLGA nanoparticles with a core-shell structure].
Tang J; Liu J; Hu TT; Yang CL; Guo G; He G; Huang Y; Zheng Y
Yao Xue Xue Bao; 2013 Feb; 48(2):298-304. PubMed ID: 23672030
[TBL] [Abstract][Full Text] [Related]
30. Redox-Sensitive Poly(lactic-
Dhamija P; Mehata AK; Tamang R; Bonlawar J; Vaishali ; Malik AK; Setia A; Kumar S; Challa RR; Koch B; Muthu MS
Mol Pharm; 2024 Jun; 21(6):2713-2726. PubMed ID: 38706253
[TBL] [Abstract][Full Text] [Related]
31. Mechanistic Analysis of Temperature-Dependent Curcumin Release from Poly(lactic-co-glycolic acid)/Poly(lactic acid) Polymer Nanoparticles.
Sunazuka Y; Ueda K; Higashi K; Wada K; Moribe K
Mol Pharm; 2024 Mar; 21(3):1424-1435. PubMed ID: 38324797
[TBL] [Abstract][Full Text] [Related]
32. Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid).
Wang G; Chen Y; Wang P; Wang Y; Hong H; Li Y; Qian J; Yuan Y; Yu B; Liu C
Acta Biomater; 2016 Jan; 29():248-260. PubMed ID: 26476340
[TBL] [Abstract][Full Text] [Related]
33. Daunorubicin oral bioavailability enhancement by surface coated natural biodegradable macromolecule chitosan based polymeric nanoparticles.
Ahmad N; Ahmad R; Alam MA; Ahmad FJ; Amir M; Pottoo FH; Sarafroz M; Jafar M; Umar K
Int J Biol Macromol; 2019 May; 128():825-838. PubMed ID: 30690115
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin.
Guo M; Rong WT; Hou J; Wang DF; Lu Y; Wang Y; Yu SQ; Xu Q
Nanotechnology; 2013 Jun; 24(24):245101. PubMed ID: 23702815
[TBL] [Abstract][Full Text] [Related]
35. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.
Elsaid N; Jackson TL; Elsaid Z; Alqathama A; Somavarapu S
Mol Pharm; 2016 Sep; 13(9):2923-40. PubMed ID: 27286558
[TBL] [Abstract][Full Text] [Related]
36. Preparation and in vitro evaluation of thienorphine-loaded PLGA nanoparticles.
Yang Y; Xie XY; Mei XG
Drug Deliv; 2016; 23(3):787-93. PubMed ID: 24870204
[TBL] [Abstract][Full Text] [Related]
37. [Formulation and process optimization of doxorubicin-loaded PLGA nanoparticles and its in vitro release].
Li JL; Zheng CL; Liu JP; Zhu JB
Yao Xue Xue Bao; 2013 May; 48(5):759-66. PubMed ID: 23888702
[TBL] [Abstract][Full Text] [Related]
38. Lawsone encapsulated polylactic-co-glycolic acid nanoparticles modified with chitosan-folic acid successfully inhibited cell growth and triggered apoptosis in Panc-1 cancer cells.
Ghafaripour H; Homayouni Tabrizi M; Karimi E; Barati Naeeni N
IET Nanobiotechnol; 2023 Jul; 17(5):425-437. PubMed ID: 37191102
[TBL] [Abstract][Full Text] [Related]
39. Enhanced sucrose-mediated cryoprotection of siRNA-loaded poly (lactic-co-glycolic acid) nanoparticles.
Youm I; West MB; Huang X; Li W; Kopke RD
Colloids Surf B Biointerfaces; 2022 Dec; 220():112880. PubMed ID: 36240574
[TBL] [Abstract][Full Text] [Related]
40. Chitosan-Modified PLGA Nanoparticles for Control-Released Drug Delivery.
Lu B; Lv X; Le Y
Polymers (Basel); 2019 Feb; 11(2):. PubMed ID: 30960288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
